Menu
  • Join
  • Login
  • Contact
 

Search abstracts


L-lactate dehydrogenase B (LDHB) is a possible predictive marker for sensitivity to anti-EGFR Mabs in colorectal cancer cell lines

  • At: 2017 FIP Congress in Stockholm (Sweden)
  • Type: Poster
  • By: NAGAMINE, Ayumu (Gunma University, Graduate School of Medicine Department of Clinical Pharmacology, Maebashi, Japan)
  • Co-author(s): Ayumu Nagamine: Department of Clinical Pharmacology, Gunma University, Maebashi, Japan;Department of Pharmacy, Gunma University Hospital, Maebashi, Japan
    Takuya Araki: Department of Clinical Pharmacology, Gunma University, Maebashi, Japan;Department of Pharmacy, Gunma University Hospital, Maebashi, Japan
    Daisuke Nagano: Department of Clinical Pharmacology, Gunma University, Maebashi, Japan
    Koujirou Yamamoto: Department of Clinical Pharmacology, Gunma University, Maebashi, Japan;Department of Pharmacy, Gunma University Hospital, Maebashi, Japan
  • Abstract:

    Backgrounds

    Recently, exploration of biomarkers with a focus on proteins derived from cancer cell to predict the efficacy of chemotherapy are widely performed. 

    Aims

    We analyzed proteins derived from colorectal cancer (CRC) cell lines with different sensitivity to cetuximab, one of anti-epidermal growth factor receptor monoclonal antibodies

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses